EPR Properties (EPR) to pay $0.38 on Sep 16, 2019; Pointstate Capital LP Cut Its Clovis Oncology (CLVS) Stake
Pointstate Capital Lp decreased Clovis Oncology Inc (CLVS) stake by 79.34% reported in 2019Q1 SEC filing. Pointstate Capital Lp sold 743,964 shares as Clovis Oncology Inc (CLVS)’s stock declined 40.43%. The Pointstate Capital Lp holds 193,712 shares with $4.81 million value, down from 937,676 last quarter. Clovis Oncology Inc now has $284.21 million valuation. The stock decreased 2.62% or $0.14 during the last trading session, reaching $5.2. About 5.95M shares traded or 122.73% up from the average. Clovis Oncology, Inc. (NASDAQ:CLVS) has declined 75.79% since August 16, 2018 and is downtrending. It has underperformed by 75.79% the S&P500. Some Historical CLVS News: 29/05/2018 – Clovis Oncology Announces European Commission Authorization of Rubraca (rucaparib) for Women With Recurre ...